Item 4.02
|
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
|
As disclosed by Air T, Inc. (Air T or the Company) in its Form 10-Q for the period ended December 31, 2015 (the
Q3 2016 Form 10-Q) and in subsequent periodic reports filed by the Company, pursuant to a Securities Purchase Agreement dated as of October 2, 2015 (the Securities Purchase Agreement) among the Company, Delphax
Technologies Inc. (Delphax) and its subsidiary, Delphax Technologies Canada Limited (Delphax Canada), on November 24, 2015 (the Closing Date), the Company purchased (i) at face value a $2,500,000
principal amount Five-Year Senior Subordinated Promissory Note (the Senior Subordinated Note) issued by Delphax Canada, and guaranteed by Delphax, for a combination of cash and the outstanding principal of $500,000 and accrued and unpaid
interest under a 90-Day Senior Subordinated Note purchased at face value by the Company from Delphax Canada on October 2, 2015 pursuant to the Securities Purchase Agreement and (ii) for $1,050,000 in cash a total of 43,000 shares of
Delphaxs Series B Preferred Stock (the Series B Preferred Stock) and a Stock Purchase Warrant (the Warrant) to acquire an additional 95,600 shares of Series B Preferred Stock at a price of $33.4728 per share (subject to
adjustment for specified dilutive events). Each share of Series B Preferred Stock is convertible into 100 shares of common stock of Delphax, subject to anti-dilution adjustments, and has no liquidation preference over shares of common stock of
Delphax. No dividends are required to be paid with respect to the shares of Series B Preferred Stock, except that ratable dividends (on an as-converted basis) are to be paid in the event that dividends are paid on the common stock of Delphax. Based
on the number of shares of Delphax common stock outstanding, the number of shares of common stock underlying the Series B Preferred Stock purchased by the Company represented approximately 38% of the shares of Delphax common stock that would be
outstanding assuming conversion of Series B Preferred Stock held by the Company. Holders of the Series B Preferred Stock, voting as a separate class, were initially entitled to elect (and exercise rights of removal and replacement) with respect to
three-sevenths of the board of directors of Delphax, and after June 1, 2016 the holders of the Series B Preferred Stock, voting as a separate class, were entitled to elect (and to exercise rights of removal and replacement of) with respect to
four-sevenths of the members of the board of directors of Delphax. The Warrant expires on November 24, 2021 and provides that in the event that dividends are paid on the common stock of Delphax, the holder of the Warrant is entitled to
participate in such dividends on a ratable basis as if the Warrant had been fully exercised and the shares of Series B Preferred Stock acquired upon such exercise had been converted into shares of Delphax common stock.
The consolidated financial statements included in the Q3 2016 Form 10-Q and in the periodic reports subsequently filed by Air T reflect the
consolidation of Delphax with the Company and its subsidiaries from the Closing Date. Such consolidated financial statements also reflect an attribution for relevant periods of 62% of Delphaxs net income or loss to non-controlling interests in
the determination of consolidated net income attributable to Air T, Inc. stockholders. Such attribution was based on the Companys ownership of the Series B Preferred Stock, which represented approximately 38% of the shares of Delphax common
stock that would be outstanding assuming conversion of Series B Preferred Stock held by the Company.
2
On October 5, 2017, the Audit Committee (the Audit Committee) of the Board of
Directors of Air T concluded that it was not appropriate to base attribution of Delphaxs net income or loss to non-controlling interests solely on the Companys ownership of the Series B Preferred Stock and that the attribution
methodology should be based on consideration of all of Air Ts investments in Delphax and Delphax Canada. As disclosed above, the Warrant provides that in the event that dividends are paid on the common stock of Delphax, the holder of the
Warrant is entitled to participate in such dividends on a ratable basis as if the Warrant had been fully exercised and the shares of Series B Preferred Stock acquired upon such exercise had been converted into shares of Delphax common stock. This
provision would have entitled Air T, Inc. to approximately 67% of any Delphax dividends paid, with the remaining 33% paid to the non-controlling interests. The Company has concluded that this was a substantive distribution right which should be
considered in the attribution of Delphax net income or loss to non-controlling interests. The Company furthermore concluded that its investment in the Senior Subordinated Promissory Note issued by Delphax Canada should be, under certain
circumstances, considered in attribution. Specifically, the Company concluded that if, through attribution of 33% of Delphax net losses to the non-controlling interests, the non-controlling interests Delphax equity balance is reduced to zero,
there could be a period during which no portion of Delphaxs net loss is attributed to the non-controlling interests due to the fact that Air T, Inc.s investment in the Senior Subordinated Promissory Note constitutes the then next most at
risk Delphax financing instrument.
As a result of the application of the above-described attribution methodology, for the relevant
periods of the financial statements listed below, the attribution of Delphax net income or losses to non-controlling interests should have been 33%, except that for the three months ended June 30, 2016, the attribution of Delphax losses to
non-controlling interests should have been 32%.
As a result, on October 5, 2017, the Audit Committee further concluded that the
financial statements for periods ending after the Companys November 24, 2015 investments in Delphax included in periodic reports filed by the Company, which includes the financial statements
|
|
|
at and for the three and nine months ended December 31, 2015 included in the Q3 2016 Form 10-Q,
|
|
|
|
at and for the fiscal year ended March 31, 2016 included in the Companys Form 10-K for the fiscal year ended March 31, 2016 (the 2016 Form 10-K),
|
|
|
|
at June 30, 2016 and March 31, 2016 and for the three months ended June 30, 2016 included in the Companys Form 10-Q for the period ended June 30, 2016 (the Q1 2017 Form 10-Q),
|
|
|
|
at September 30, 2016 and March 31, 2016 and for the three and six months ended September 30, 2016 included in the Companys Form 10-Q for the period ended September 30, 2016 (the Q2 2017
Form 10-Q), and
|
|
|
|
at December 31, 2016 and March 31, 2016 and for the three and nine months ended December 31, 2016 and 2015 included in the Companys Form 10-Q for the period ended December 31, 2016 (together
with the Q1 2017 Form 10-Q and the Q2 2017 Form 10-Q, the 2017 Form 10-Qs, and such financial statements in the Q3 2016 Form 10-Q, the 2016 Form 10-K and the 2017 Form 10-Qs being collectively referred to as the Subject Financial
Statements)
|
3
may no longer be relied upon to the extent the Subject Financial Statements reflect the attribution of 62% of
Delphaxs net income or loss to non-controlling interests for the respective periods covered by the Subject Financial Statements.
The Audit Committees conclusions followed discussions among the Company, the Audit Committee and the Companys independent
registered public accounting firms.
The Company intends to amend the Q3 2016 Form 10-Q, 2016 Form 10-K and the 2017 Form 10-Qs as
promptly as is practicable to restate the Subject Financial Statements to reflect attribution of Delphaxs net income or loss for the relevant periods based on consideration of all of Air Ts investments in Delphax and Delphax Canada as
described above. The amount of the Companys consolidated net income (loss) (which is presented prior to attribution of net loss (income) attributable to non-controlling interests in the Companys consolidated statements of income) to be
presented in such restated financial statements will not differ from the consolidated net income (loss) previously reported in the respective Subject Financial Statements. Similarly, the correction of the attribution of Delphaxs net income or
loss for the relevant periods will not affect the Companys assets, liabilities or cash flows at and for each of these periods from the amounts previously reported in the respective Subject Financial Statements.
4